Robuta

https://www.globenewswire.com/fr/news-release/2026/01/08/3215050/0/en/tensive-reports-positive-pivotal-trial-top-line-results-showing-regenera-bioresorbable-device-may-transform-breast-reconstruction.html Tensive reports positive pivotal trial top-line results Clinical data from pivotal trial in patients undergoing lumpectomy confirm strong safety profile and growing performance benefits Primary safety endpoint... pivotal trialtop linereportspositiveresults https://k2radio.com/weinstein-rape-accuser-testifying-in-pivotal-trial-moment/ Weinstein Rape Accuser Testifying in Pivotal Trial Moment Weinstein has insisted any sexual encounters were consensual. pivotal trialweinsteinrapeaccusertestifying https://www.epistemonikos.org/en/documents/5cfc7427624e017566eb71c5e36431e59f35496e Pivotal trial with intravenous plasminogen replacement in patients with plasminogen deficiency... pivotal trialin patientsintravenousreplacementdeficiency https://millerscientific.com/publication/transcervical-fibroid-ablation-pivotal-trial/ Transcervical fibroid ablation pivotal trial - Miller Scientific pivotal trialfibroidablationmillerscientific https://researchconnect.buffalo.edu/en/publications/pivotal-trial-of-the-neuroform-atlas-stent-for-treatment-of-anter/ Pivotal Trial of the Neuroform Atlas Stent for Treatment of Anterior Circulation Aneurysms:... pivotal trialof the https://www.medtechdive.com/news/jj-laminar-laa-pivotal-trial/708777/ J&J begins enrolling patients in Laminar LAA pivotal trial | MedTech Dive The new device is meant to compete with systems offered by Boston Scientific and Abbott that address blood clot risk in atrial fibrillation. pivotal trialjbeginsenrollingpatients https://www.cambium.bio/investors/fda-confirms-single-pivotal-trial-pathway-for-elate-ocular FDA Confirms Single Pivotal Trial Pathway for Elate Ocular - Cambium Bio Cambium Bio is a patient-focused, clinical-stage, regenerative medicine company developing a pioneering platform in ophthalmology and tissue regeneration. pivotal trialfdaconfirmssingle https://pharmadevicenews.com/theriva-biologics-leverages-fda-and-ema-feedback-to-optimize-vcn-01-pivotal-trial/ Theriva Biologics leverages FDA and EMA feedback to optimize VCN-01 pivotal trial - PharmaDeviceNews Mar 24, 2026 - Theriva Biologics advances VCN-01 into phase 3 for metastatic pancreatic cancer with FDA and EMA guidance. Explore trial design, dosing strategy, and risks. https://business.am-news.com/am-news/article/gnwcq-2024-1-26-femasys-inc-begins-fembloc-pivotal-trial-enrollment-at-uc-davis-medical-center-a-hub-for-innovation-and-groundbreaking-research-in-health-care-for-women News | postregister.com - Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical... Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women https://www.natap.org/2025/HIV/122325_01.htm Merck Announces Positive Topline Results from the Pivotal Phase 3 Trial Evaluating Investigational,... https://www.puertoricohealthcaredaily.com/article/910488144-anteris-technologies-announces-first-u-s-patients-treated-in-global-pivotal-paradigm-trial Anteris Technologies Announces First U.S. Patients Treated in Global Pivotal PARADIGM Trial |... https://cepi.net/cepi-fund-pivotal-phase-3-trial-modernas-mrna-pandemic-influenza-candidate CEPI to Fund Pivotal Phase 3 Trial for Moderna’s mRNA Pandemic Influenza Candidate Partnership strengthens global preparedness against a significant pandemic threat https://skytrofahcp.com/aghd/efficacy/foresight-trial/ PIVOTAL Phase 3 foresiGHt Trial Safety and efficacy in adults withGHD Feb 3, 2026 - Review safety and efficacy in adults with GHD. See fullPrescribing and Safety Info. safety and efficacypivotalphaseforesighttrial https://www.biospace.com/hansa-announces-first-patient-dosed-with-imlifidase-in-a-global-pivotal-phase-3-trial-in-anti-glomerular-basement-membrane-anti-gbm-disease Hansa announces first patient dosed with imlifidase in a global pivotal phase 3 trial in... May 30, 2023 - Hansa Biopharma, a pioneer in enzyme technology for rare immunological conditions, announced the first patient has been dosed with imlifidase in the... https://www.biospace.com/dermata-announces-achievement-of-50-enrollment-in-pivotal-dmt310-phase-3-star-1-clinical-trial-for-acne Dermata Announces Achievement of 50% Enrollment in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for... https://sperlingprostatecenter.com/long-term-pivot-trial-results-support-pivotal-prostate-cancer-choices/ Long-term PIVOT Trial Results Support Pivotal Prostate Cancer Choices - Sperling Prostate Center Aug 26, 2024 - Long-term results of the PIVOT trial reveal that prostatectomy has no significant advantage over observation for men with low-risk prostate cancer long termtrial results